安集科技(688019.SH):持股4.68%的張江科創擬減持不超1%的股份
格隆匯 11 月 8日丨安集科技(688019.SH)公佈,截至公告披露日,上海張江科技創業投資有限公司(“張江科創”)持有公司股份248.6735萬股,佔公司總股本4.68%。上述股份均為無限售條件流通股且來源均為公司首次公開發行股票並上市前取得的股份。
因自身資金需求,張江科創計劃自公告披露之日起15個交易日之後的一定期間內(2020年11月30日至2021年1月31日),通過集中競價方式減持公司股份不超過53.1083萬股,減持股份佔公司總股本的比例不超過1%。
減持價格將根據市場價格確定。若公司在上述期間內發生送股、資本公積金轉增股本等股份變動事項,將對擬減持股份數量進行相應調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.